Skip to main content

AstraZeneca reaches deal to buy CinCor Pharma for up to $1.8B

The deal includes an upfront payment of $1.3 billion
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.